Időskori makuladegeneráció: vizsgálatok itt: Lengyelország
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- Bydgoszcz, Cracow, Tarnowskie Góry
- Életkor
- 50 év and over
- People
- 272 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00 - 3. fázisTaking peopleA Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
- Where
- Bielsko-Biala, Bydgoszcz, Cracow, Gliwice, Katowice, Lodz, Lublin, Olsztyn
- Életkor
- 50 év and over
- People
- 250 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00 - 3. fázisTaking peopleA Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Where
- Bydgoszcz, Cracow, Lodz, Olsztyn, Rzeszów, Tarnowskie Góry, Wroclaw
- Életkor
- 50 év to 85 év
- People
- 975 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00 - 2/3. fázisTaking peopleA Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Where
- Bydgoszcz, Warsaw
- Életkor
- 60 év and over
- People
- 274 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00 - 3. fázisTaking peopleA Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
- Where
- Bydgoszcz, Cracow, Lodz, Olsztyn, Rzeszów, Tarnowskie Góry, Warsaw
- Életkor
- 50 év and over
- People
- 304 worldwide
- Run by
- Amgen
See details and how to joinNCT07614776 · EU 2025-523500-72-00 - 2/3. fázisTaking peopleA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Where
- Bydgoszcz, Gdansk, Katowice, Krakow, Olsztyn, Tarnowskie Góry
- Életkor
- 50 év and over
- People
- 960 worldwide
- Run by
- EyeBiotech Ltd.
See details and how to joinNCT07440225 - 2. fázisCsak meghívásosORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
- Where
- Bydgoszcz
- Életkor
- 55 év and over
- People
- 225 worldwide
- Run by
- Gyroscope Therapeutics Limited
See details and how to joinNCT05481827 · EU 2024-510946-15-00 - 2/3. fázisNot yet taking people in LengyelországA Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
- Where
- Bydgoszcz, Cracow, Gdansk, Lodz, Lublin, Olsztyn, Warsaw
- Életkor
- 65 év and over
- People
- 125 worldwide
- Run by
- Shenzhen Oculgen Biomedical Technology Co. Ltd.
See details and how to join2026-526648-11-00 · EU 2026-526648-11-00 - 2. fázisTaking peopleA Study in Adults With Geographic Atrophy
- Where
- Bielsko-Biala, Bydgoszcz, Cracow, Katowice, Olsztyn, Poznan, Walbrzych, Warsaw
- Életkor
- 60 év and over
- People
- 300 worldwide
- Run by
- Sitala Bio LTD
See details and how to joinNCT07606365 · EU 2026-525738-40-00 - 3. fázisTaking peopleVitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
- Where
- Cracow, Lodz, Warsaw
- Életkor
- 50 év to 120 év
- People
- 210 worldwide
- Run by
- King's College Hospital NHS Trust
See details and how to joinNCT04663750 · EU 2023-504751-28-00 - 2. fázisTaking peopleStudy to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Where
- Bydgoszcz, Cracow, Gdansk, Lodz, Olsztyn
- Életkor
- 55 év and over
- People
- 324 worldwide
- Run by
- ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00 - 2/3. fázisTaking peopleA randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)
- Where
- Bialystok, Bydgoszcz, Cracow, Gdansk, Katowice, Olsztyn, Tarnowskie Góry, Warsaw
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Eyebiotech Limited
See details and how to join2025-524575-22-00 · EU 2025-524575-22-00